With reference to the earlier Announcement dated August 13, 2015, regarding Q1 FY 16 Investor Relation Report, Sunil Healthcare has informed that there was a typographical error on PAT amount of Q1FY2015. In earlier presentation the PAT for Q1FY2015 has been shown as Rs 68 Million whereas the correct PAT was Rs 6.80 Million, which is now corrected in Revised Q1FY16 Investor Relation Report. Now the Company has submitted Revised Copy of ‘Q1FY16 Investor Relation Report’
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3645.70 |
| Tata Chemicals | 795.00 |
| SRF | 2528.40 |
| Pidilite Inds. | 1358.80 |
| Deepak Nitrite | 1765.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: